{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:42:21Z","timestamp":1700786541024},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00108-023-01622-x","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T07:01:48Z","timestamp":1699599708000},"page":"1143-1153","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Was ist gesichert in der Therapie des isch\u00e4mischen Schlaganfalls?","What is confirmed in the treatment of ischemic stroke"],"prefix":"10.1007","volume":"64","author":[{"given":"Hans","family":"Worthmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit M.","family":"Grosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"issue":"10","key":"1622_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBD 2019 Stroke Collaborators","year":"2021","unstructured":"GBD 2019 Stroke Collaborators (2021) Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a\u00a0systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 20(10):795\u2013820","journal-title":"Lancet Neurol"},{"issue":"24","key":"1622_CR2","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","unstructured":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N\u00a0Engl J Med 333(24):1581\u20131587","journal-title":"N Engl J Med"},{"issue":"10029","key":"1622_CR3","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal\u00a0M et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a\u00a0meta-analysis of individual patient data from five randomised trials. Lancet 387(10029):1723\u20131731","journal-title":"Lancet"},{"key":"1622_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000197.pub3","author":"Stroke Unit Trialists\u2019 Collaboration","year":"2013","unstructured":"Stroke Unit Trialists\u2019 Collaboration (2013) Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD000197.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"1622_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11883-017-0695-5","volume":"19","author":"KM Kelly","year":"2017","unstructured":"Kelly\u00a0KM et\u00a0al (2017) Community interventions to increase stroke preparedness and acute stroke treatment rates. Curr Atheroscler Rep 19(12):64","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"1622_CR6","first-page":"e111","volume":"49","author":"EE Smith","year":"2018","unstructured":"Smith\u00a0EE et\u00a0al (2018) Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: a\u00a0systematic review for the 2018 guidelines for the early management of patients with acute Ischemic stroke. Stroke 49(3):e111\u2013e122","journal-title":"Stroke"},{"key":"1622_CR7","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"P Ringleb","year":"2022","unstructured":"Ringleb\u00a0P et al (2022) Akuttherapie des isch\u00e4mischen Schlaganfalls, S2e-Leitlinie. In: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie (http:\/\/www.dgn.org\/leitlinien. Zugegriffen: 02.\u00a0Oktober 2023)"},{"issue":"13","key":"1622_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke\u00a0W et\u00a0al (2008) Thrombolysis with alteplase 3 to 4.5\u00a0hours after acute ischemic stroke. N\u00a0Engl J Med 359(13):1317\u20131329","journal-title":"N Engl J Med"},{"issue":"9958","key":"1622_CR9","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","volume":"384","author":"J Emberson","year":"2014","unstructured":"Emberson\u00a0J et al (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a\u00a0meta-analysis of individual patient data from randomised trials. Lancet 384(9958):1929\u20131935","journal-title":"Lancet"},{"issue":"10262","key":"1622_CR10","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/S0140-6736(20)32163-2","volume":"396","author":"G Thomalla","year":"2020","unstructured":"Thomalla\u00a0G et al (2020) Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data. Lancet 396(10262):1574\u20131584","journal-title":"Lancet"},{"issue":"4","key":"1622_CR11","doi-asserted-by":"publisher","first-page":"e014265","DOI":"10.1161\/JAHA.119.014265","volume":"9","author":"M Sykora","year":"2020","unstructured":"Sykora\u00a0M et al (2020) Thrombolysis in stroke with unknown onset based on non-contrast computerized tomography (TRUST CT). J\u00a0Am Heart Assoc 9(4):e14265","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"1622_CR12","doi-asserted-by":"publisher","first-page":"e1241","DOI":"10.1212\/WNL.0000000000008904","volume":"94","author":"G Tsivgoulis","year":"2020","unstructured":"Tsivgoulis\u00a0G, Katsanos\u00a0AH, Malhotra\u00a0K et\u00a0al (2020) Thrombolysis for acute ischemic stroke in the unwitnessed or extended therapeutic time window. Neurology 94(12):e1241\u2013e1248","journal-title":"Neurology"},{"issue":"4","key":"1622_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00115-018-0633-y","volume":"90","author":"DG Nabavi","year":"2018","unstructured":"Nabavi\u00a0DG et al (2018) Zertifizierungskriterien f\u00fcr Stroke-Units in Deutschland: Update 2018. Nervenarzt 90(4):335\u2013342","journal-title":"Nervenarzt"},{"issue":"15","key":"1622_CR14","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1056\/NEJMoa2206317","volume":"387","author":"C Tao","year":"2022","unstructured":"Tao\u00a0C et al (2022) Trial of endovascular treatment of acute basilar-artery occlusion. N\u00a0Engl J Med 387(15):1361\u20131372","journal-title":"N Engl J Med"},{"issue":"15","key":"1622_CR15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJMoa2207576","volume":"387","author":"TG Jovin","year":"2022","unstructured":"Jovin\u00a0TG et al (2022) Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. N\u00a0Engl J Med 387(15):1373\u20131384","journal-title":"N Engl J Med"},{"issue":"1","key":"1622_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1706442","volume":"378","author":"RG Nogueira","year":"2018","unstructured":"Nogueira\u00a0RG et\u00a0al (2018) Thrombectomy 6 to 24 hours after stroke with a\u00a0mismatch between deficit and infarct. N\u00a0Engl J Med 378(1):11\u201321","journal-title":"N Engl J Med"},{"issue":"8","key":"1622_CR17","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1056\/NEJMoa1713973","volume":"378","author":"GW Albers","year":"2018","unstructured":"Albers\u00a0GW et\u00a0al (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N\u00a0Engl J Med 378(8):708\u2013718","journal-title":"N Engl J Med"},{"issue":"12","key":"1622_CR18","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2016.13647","volume":"316","author":"JL Saver","year":"2016","unstructured":"Saver\u00a0JL et al (2016) Time to treatment with endovascular thrombectomy and outcomes from Ischemic stroke: a\u00a0meta-analysis. JAMA 316(12):1279\u20131288","journal-title":"JAMA"},{"issue":"2","key":"1622_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/neurintsurg-2013-010665","volume":"6","author":"M Goyal","year":"2014","unstructured":"Goyal\u00a0M et\u00a0al (2014) 2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J\u00a0Neurointerv Surg 6(2):83\u201386","journal-title":"J Neurointerv Surg"},{"issue":"1","key":"1622_CR20","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/23969873221076968","volume":"7","author":"G Turc","year":"2022","unstructured":"Turc\u00a0G et\u00a0al (2022) European Stroke Organisation\u2014European Society for Minimally Invasive Neurological Therapy expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischaemic stroke and anterior circulation large vessel occlusion. Eur Stroke\u00a0J 7(1):I\u2013XXVI","journal-title":"Eur Stroke J"},{"issue":"2","key":"1622_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jamaneurol.2020.3745","volume":"78","author":"H Reinink","year":"2021","unstructured":"Reinink\u00a0H et al (2021) Surgical decompression for space-occupying hemispheric infarction: a\u00a0systematic review and individual patient meta-analysis of randomized clinical trials. JAMA Neurol 78(2):208\u2013216","journal-title":"JAMA Neurol"},{"issue":"1","key":"1622_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams\u00a0HP Jr et\u00a0al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a\u00a0multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35\u201341","journal-title":"Stroke"},{"issue":"12","key":"1622_CR23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart\u00a0RG et al (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146(12):857\u2013867","journal-title":"Ann Intern Med"},{"issue":"Suppl I","key":"1622_CR24","doi-asserted-by":"publisher","first-page":"I13","DOI":"10.1093\/eurheartj\/suaa104","volume":"22","author":"HC Diener","year":"2020","unstructured":"Diener\u00a0HC et al (2020) Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation. Eur Heart\u00a0J 22(Suppl I):I13\u2013i21","journal-title":"Eur Heart J"},{"key":"1622_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008980.pub3","author":"KM Bruins Slot","year":"2018","unstructured":"Bruins Slot\u00a0KM et\u00a0al (2018) Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008980.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"1622_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/17474930231184366","author":"GM Grosse","year":"2023","unstructured":"Grosse\u00a0GM et al (2023) Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: the PRODAST study. Int J Stroke. https:\/\/doi.org\/10.1177\/17474930231184366","journal-title":"Int J Stroke"},{"issue":"1","key":"1622_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January\u00a0CT et\u00a0al (2019) AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A\u00a0Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J\u00a0Am Coll Cardiol 74(1):104\u2013132","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1622_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2396987319841187","volume":"4","author":"CJ Klijn","year":"2019","unstructured":"Klijn\u00a0CJ et al (2019) Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A\u00a0European Stroke Organisation guideline. Eur Stroke\u00a0J 4(3):198\u2013223","journal-title":"Eur Stroke J"},{"issue":"10","key":"1622_CR29","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel\u00a0J et al (2021) European heart rhythm association practical guide on the use of non-vitamin\u00a0K antagonist oral anticoagulants in patients with atrial fibrillation. Europace 23(10):1612\u20131676","journal-title":"Europace"},{"issue":"7","key":"1622_CR30","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1161\/STROKEAHA.118.021514","volume":"49","author":"AE Groot","year":"2018","unstructured":"Groot\u00a0AE et\u00a0al (2018) Continuation or discontinuation of anticoagulation in the early phase after acute Ischemic stroke. Stroke 49(7):1762\u20131765","journal-title":"Stroke"},{"issue":"7","key":"1622_CR31","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/heartjnl-2020-317887","volume":"107","author":"LA Garc\u00eda Rodr\u00edguez","year":"2021","unstructured":"Garc\u00eda Rodr\u00edguez\u00a0LA et\u00a0al (2021) Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke. Heart 107(7):542\u2013548","journal-title":"Heart"},{"key":"1622_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1474-4422(18)30356-9","volume":"18","author":"DJ Seiffge","year":"2019","unstructured":"Seiffge\u00a0DJ et\u00a0al (2019) Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol 18:117\u2013126","journal-title":"Lancet Neurol"},{"key":"1622_CR33","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","volume":"146","author":"J Oldgren","year":"2022","unstructured":"Oldgren\u00a0J et al (2022) Early versus delayed non-vitamin\u00a0K antagonist oral anticoagulant therapy after acute Ischemic stroke in atrial fibrillation (TIMING): a\u00a0registry-based randomized controlled Noninferiority study. Circulation 146:1056\u20131066","journal-title":"Circulation"},{"key":"1622_CR34","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","volume":"388","author":"U Fischer","year":"2023","unstructured":"Fischer\u00a0U et\u00a0al (2023) Early versus later anticoagulation for stroke with atrial fibrillation. N\u00a0Engl J Med 388:2411\u20132421","journal-title":"N Engl J Med"},{"key":"1622_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/17474930211057722","volume":"17","author":"JG Best","year":"2022","unstructured":"Best\u00a0JG et\u00a0al (2022) Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a\u00a0randomized controlled trial. Int J Stroke 17:583\u2013589","journal-title":"Int J Stroke"},{"key":"1622_CR36","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1177\/1747493019870651","volume":"14","author":"BT King","year":"2019","unstructured":"King\u00a0BT et al (2019) Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): methodology of a\u00a0pragmatic, response-adaptive, prospective randomized clinical trial. Int J Stroke 14:977\u2013982","journal-title":"Int J Stroke"},{"key":"1622_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1177\/23969873211060219","volume":"6","author":"GM Grosse","year":"2021","unstructured":"Grosse\u00a0GM et\u00a0al (2021) Rationale, design and methods of the prospective record of the use of dabigatran in patients with acute stroke or TIA (PRODAST) study. Eur Stroke\u00a0J 6:438\u2013444","journal-title":"Eur Stroke J"},{"key":"1622_CR38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/a-1814-2536","volume":"41","author":"C Skurk","year":"2022","unstructured":"Skurk\u00a0C et\u00a0al (2022) Perkutaner Vorhofohrverschluss. Nervenheilkunde 41:417\u2013423","journal-title":"Nervenheilkunde"},{"issue":"3","key":"1622_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ejvs.2007.11.006","volume":"35","author":"PM Rothwell","year":"2008","unstructured":"Rothwell\u00a0PM (2008) Prediction and prevention of stroke in patients with symptomatic carotid stenosis: the high-risk period and the high-risk patient. Eur J Vasc Endovasc Surg 35(3):255\u2013263","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1622_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001081.pub3","author":"S Orrapin","year":"2017","unstructured":"Orrapin\u00a0S et\u00a0al (2017) Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD001081.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1622_CR41","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/23969873211012121","volume":"6","author":"LH Bonati","year":"2021","unstructured":"Bonati\u00a0LH et\u00a0al (2021) European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. Eur Stroke\u00a0J 6(2):I\u2013XLVII","journal-title":"Eur Stroke J"},{"key":"1622_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000515.pub4","author":"LH Bonati","year":"2012","unstructured":"Bonati\u00a0LH et\u00a0al (2012) Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD000515.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"1622_CR43","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa1505215","volume":"374","author":"TG Brott","year":"2016","unstructured":"Brott\u00a0TG et al (2016) Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N\u00a0Engl J Med 374(11):1021\u20131031","journal-title":"N Engl J Med"},{"issue":"12","key":"1622_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11936-019-0796-2","volume":"21","author":"S Silverman","year":"2019","unstructured":"Silverman\u00a0S (2019) Management of asymptomatic carotid artery stenosis. Curr Treat Options Cardio Med 21(12):80","journal-title":"Curr Treat Options Cardio Med"},{"issue":"10305","key":"1622_CR45","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0140-6736(21)01910-3","volume":"398","author":"A Halliday","year":"2021","unstructured":"Halliday\u00a0A et al (2021) Second asymptomatic carotid surgery trial (ACST-2): a\u00a0randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet 398(10305):1065\u20131073","journal-title":"Lancet"},{"issue":"3","key":"1622_CR46","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1161\/STROKEAHA.119.028528","volume":"51","author":"B Flusty","year":"2020","unstructured":"Flusty\u00a0B et\u00a0al (2020) Intracranial atherosclerosis treatment. Stroke 51(3):e49\u2013e53","journal-title":"Stroke"},{"issue":"4","key":"1622_CR47","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","volume":"13","author":"RG Hart","year":"2014","unstructured":"Hart\u00a0RG et\u00a0al (2014) Embolic strokes of undetermined source: the case for a\u00a0new clinical construct. Lancet Neurol 13(4):429\u2013438","journal-title":"Lancet Neurol"},{"issue":"20","key":"1622_CR48","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","volume":"380","author":"HC Diener","year":"2019","unstructured":"Diener\u00a0HC et\u00a0al (2019) Dabigatran for prevention of stroke after embolic stroke of undetermined source. N\u00a0Engl J Med 380(20):1906\u20131917","journal-title":"N Engl J Med"},{"issue":"23","key":"1622_CR49","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","volume":"378","author":"RG Hart","year":"2018","unstructured":"Hart\u00a0RG et\u00a0al (2018) Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N\u00a0Engl J Med 378(23):2191\u20132201","journal-title":"N Engl J Med"},{"issue":"22","key":"1622_CR50","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1161\/CIRCULATIONAHA.119.040267","volume":"140","author":"RB Schnabel","year":"2019","unstructured":"Schnabel\u00a0RB et al (2019) Searching for atrial fibrillation poststroke: a\u00a0white paper of the AF-SCREEN international collaboration. Circulation 140(22):1834\u20131850","journal-title":"Circulation"},{"issue":"8","key":"1622_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41582-022-00663-4","volume":"18","author":"HC Diener","year":"2022","unstructured":"Diener\u00a0HC et\u00a0al (2022) Review and update of the concept of embolic stroke of undetermined source. Nat Rev Neurol 18(8):455\u2013465","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"1622_CR52","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1177\/23969873231182492","volume":"8","author":"EM Sievering","year":"2023","unstructured":"Sievering\u00a0EM et al (2023) Diagnostic value of carotid intima-media thickness and clinical risk scores in determining etiology of ischemic stroke. Eur Stroke\u00a0J 8(3):738\u2013746","journal-title":"Eur Stroke J"},{"issue":"2","key":"1622_CR53","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","volume":"49","author":"G Ntaios","year":"2018","unstructured":"Ntaios\u00a0G et\u00a0al (2018) Closure of patent foramen Ovale versus medical therapy in patients with cryptogenic stroke or transient Ischemic attack. Stroke 49(2):412\u2013418","journal-title":"Stroke"},{"key":"1622_CR54","unstructured":"Diener H\u2011C et al (2018) Kryptogener Schlaganfall und offenes Foramen ovale, S2e-Leitlinie. Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. https:\/\/register.awmf.org\/assets\/guidelines\/030-142l_S2e_Kryptogener_Schlaganfall_2018-08-verlaengert.pdf. Zugegriffen: 9. Okt. 2023"},{"issue":"7","key":"1622_CR55","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","volume":"81","author":"DM Kent","year":"2013","unstructured":"Kent\u00a0DM et al (2013) An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 81(7):619\u2013625","journal-title":"Neurology"},{"issue":"3","key":"1622_CR56","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1161\/STROKEAHA.120.031237","volume":"52","author":"H-C Diener","year":"2021","unstructured":"Diener\u00a0H\u2011C et al (2021) Dabigatran or Aspirin after embolic stroke of undetermined source in patients with patent foramen ovale. Stroke 52(3):1065\u20131068","journal-title":"Stroke"},{"issue":"1","key":"1622_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang\u00a0Y et\u00a0al (2013) Clopidogrel with Aspirin in acute minor stroke or transient ischemic attack. N\u00a0Engl J Med 369(1):11\u201319","journal-title":"N Engl J Med"},{"issue":"3","key":"1622_CR58","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston\u00a0SC et al (2018) Clopidogrel and Aspirin in acute ischemic stroke and high-risk TIA. N\u00a0Engl J Med 379(3):215\u2013225","journal-title":"N Engl J Med"},{"issue":"12","key":"1622_CR59","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1001\/jamaneurol.2019.2531","volume":"76","author":"Y Pan","year":"2019","unstructured":"Pan\u00a0Y et al (2019) Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a\u00a0pooled analysis of clopidogrel in high-risk patients with acute non-disabling cerebrovascular events (CHANCE) and platelet-oriented inhibition in new TIA and minor Ischemic stroke (POINT) trials. JAMA Neurol 76(12):1466\u20131473","journal-title":"JAMA Neurol"},{"key":"1622_CR60","doi-asserted-by":"publisher","first-page":"k5108","DOI":"10.1136\/bmj.k5108","volume":"363","author":"Q Hao","year":"2018","unstructured":"Hao\u00a0Q et al (2018) Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis. BMJ 363:k5108","journal-title":"BMJ"},{"issue":"7","key":"1622_CR61","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer\u00a0DO et\u00a0al (2021) 2021 guideline for the prevention of stroke in patients with stroke and transient Ischemic attack: a\u00a0guideline from the American Heart Association\/American stroke association. Stroke 52(7):e364\u2013e467","journal-title":"Stroke"},{"key":"1622_CR62","doi-asserted-by":"publisher","first-page":"923142","DOI":"10.3389\/fneur.2022.923142","volume":"13","author":"CJ Lin","year":"2022","unstructured":"Lin\u00a0CJ et\u00a0al (2022) Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis. Front Neurol 13:923142","journal-title":"Front Neurol"},{"issue":"3","key":"1622_CR63","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1916870","volume":"383","author":"SC Johnston","year":"2020","unstructured":"Johnston\u00a0SC et\u00a0al (2020) Ticagrelor and aspirin or Aspirin alone in acute Ischemic stroke or TIA. N\u00a0Engl J Med 383(3):207\u2013217","journal-title":"N Engl J Med"},{"key":"1622_CR64","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT04078737. Zugegriffen: 9. Okt. 2023"},{"issue":"4","key":"1622_CR65","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1001\/jamaneurol.2021.5578","volume":"79","author":"M Lee","year":"2022","unstructured":"Lee\u00a0M et al (2022) Association between intensity of low-density lipoprotein cholesterol reduction with statin-based therapies and secondary stroke prevention: a\u00a0meta-analysis of randomized clinical trials. JAMA Neurol 79(4):349\u2013358","journal-title":"JAMA Neurol"},{"issue":"1","key":"1622_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa1910355","volume":"382","author":"P Amarenco","year":"2020","unstructured":"Amarenco\u00a0P et\u00a0al (2020) A comparison of two LDL cholesterol targets after Ischemic stroke. N\u00a0Engl J Med 382(1):9","journal-title":"N Engl J Med"},{"issue":"4","key":"1622_CR67","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/STROKEAHA.119.028718","volume":"51","author":"P Amarenco","year":"2020","unstructured":"Amarenco\u00a0P et al (2020) Treat stroke to target investigators. Benefit of targeting a\u00a0LDL (low-density lipoprotein) cholesterol \u3008\u202f70\u202fmg\/dL during 5 years after Ischemic stroke. Stroke 51(4):1231\u20131239","journal-title":"Stroke"},{"key":"1622_CR68","doi-asserted-by":"crossref","unstructured":"Oesterle A et\u00a0al Pleiotropic effects of statins on the cardiovascular system. Circ Res 120(1):229\u2013243","DOI":"10.1161\/CIRCRESAHA.116.308537"},{"issue":"8","key":"1622_CR69","doi-asserted-by":"publisher","first-page":"e005658","DOI":"10.1161\/JAHA.117.005658","volume":"6","author":"M Lee","year":"2017","unstructured":"Lee\u00a0M et al (2017) Utilization of statins beyond the initial period after stroke and 1\u2011year risk of recurrent stroke. J\u00a0Am Heart Assoc 6(8):e5658","journal-title":"J Am Heart Assoc"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01622-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-023-01622-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01622-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T10:02:30Z","timestamp":1700733750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-023-01622-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1622"],"URL":"https:\/\/doi.org\/10.1007\/s00108-023-01622-x","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"20 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Die Autoren geben an, als Pr\u00fcf\u00e4rzte in den klinischen Studien POINT, RE-SPECT ESUS, NAVIGATE-ESUS, THALES und PRODAST t\u00e4tig gewesen zu sein. H.\u00a0Worthmann erh\u00e4lt Forschungsf\u00f6rderung durch die Else-Kr\u00f6ner-Fresenius-Stiftung. J.\u00a0Ernst wird unterst\u00fctzt durch das Clinician Scientist Programm PRACTIS, gef\u00f6rdert von der Deutschen Forschungsgemeinschaft (DFG, ME 3696\/3\u20101). G.\u202fM.\u00a0Grosse erh\u00e4lt Forschungsf\u00f6rderungen durch das Bundesministerium f\u00fcr Bildung und Forschung, das Nieders\u00e4chsische Ministerium f\u00fcr Wissenschaft und Kultur und der Europ\u00e4ischen Kommission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}